Chen Jiehui 陈杰辉
Vice Chairman and General ManagerGuangzhou Pharmaceutical Holdings
PharmaceuticalsView Profile →Member of the Board of Management — Pharmaceuticals · Bayer
Stefan Oelrich leads Bayer’s Pharmaceuticals Division and sits on its Board of Management. His career spans Bayer’s international healthcare businesses and Sanofi’s diabetes and cardiovascular operations.
Last reviewed: Nov 15, 2026
Stefan Oelrich leads Bayer’s Pharmaceuticals Division and sits on its Board of Management. His career spans Bayer’s international healthcare businesses and Sanofi’s diabetes and cardiovascular operations.
Oelrich entered Bayer through commercial training in 1989, qualifying as a commercial assistant in 1991. His early healthcare assignments took him to Argentina and Uruguay, followed by a return to Leverkusen headquarters in 1998. He subsequently led Pharmaceuticals in Belgium.
From 2003 to 2005 he was vice president of pharmaceutical marketing in the United States. He then became president of Healthcare and Diagnostics in France, returning to the United States in 2006 as senior vice president and general manager for Women’s Healthcare.
He moved to Sanofi in 2011 to lead Germany, Switzerland and Austria. In 2015 he took responsibility for the European diabetes and cardiovascular business while coordinating Sanofi’s European activities. He became global diabetes franchise head in June 2016. Sanofi’s October 2017 announcement also records an intervening assignment as acting head of its North American diabetes and cardiovascular business.
Sanofi appointed him executive vice president for Diabetes & Cardiovascular and an executive committee member in October 2017. He returned to Bayer as Pharmaceuticals head and management board member on November 1, 2018. His subsequent external appointments include Charité’s supervisory board and the presidency of EFPIA.
No institution-specific degree entry is listed.